Innoviva INVA
NASDAQ INVA
$20.55 -0.66 (-3.11%)
At close: Oct 1, 2026 · 4:00 PM EDT

Innoviva (INVA) Other Operating Expenses (2013 - 2023)

Updated

Innoviva's Other Operating Expenses was -$51.32 million in Q4 2023, compared with -$258.7 million a year earlier.

Analysis

Innoviva (INVA) Other Operating Expenses (2013 - 2023) Analysis & Trends

For FY2023, Other Operating Expenses at Innoviva came in at -$11.75 million.

  • In earlier years, Other Operating Expenses was -$60.58 million in FY2022, -$70.17 million in FY2021 and -$33.12 million in FY2020.
  • Quarterly Other Operating Expenses has moved between -$258.7 million (Q4 2022) and $62.06 million (Q2 2022) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Innoviva 1.54 Bn -750.13 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -51.32 Mn
Jun 30, 2023 36.66 Mn
Mar 31, 2023 2.91 Mn
Sep 30, 2022 -258.70 Mn
Jun 30, 2022 62.06 Mn
Mar 31, 2022 33.01 Mn
Dec 31, 2021 48.04 Mn
Sep 30, 2021 -28.62 Mn
Dec 31, 2020 -33.12 Mn
Mar 31, 2018 2.70 Mn
Mar 31, 2013 -26.64 Mn
API Access

Innoviva Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=INVA&period=max&api_key=YOUR_API_KEY